SLC2A1 and neoplasm: iCAFs and myCAFs upregulate GLUT1 and LDH, transport lactate to tumor cells through MCT4 (29), activate the HIF-1α pathway, induce the expression of drug resistance genes such as MDR1, and increase drug resistance in tumor cells (30, 31).